» Articles » PMID: 28299320

Etiology of End-Stage Renal Disease and Arterial Stiffness Among Hemodialysis Patients

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2017 Mar 17
PMID 28299320
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

. Prior studies have demonstrated that conventional and emerging CV risk factors are associated with worsening arterial stiffness among end-stage renal disease (ESRD) patients on hemodialysis. The present cross-sectional study evaluates the association between the etiology of ESRD and arterial stiffness among a cohort of hemodialysis patients. . Etiology of ESRD was identified from patients' medical records and classified as either vascular renal disease, diabetic nephropathy, nondiabetic glomerulopathy, tubular interstitial nephropathy, hereditary nephropathy, or ESRD of unconfirmed etiology. . A total of 82 subjects were enrolled. cfPWV was independently associated with the composite of either diabetic nephropathy or vascular renal disease ( = 0.022), pulse pressure ( = 0.001), and a history of CV events ( = 0.025), but not history of hypertension or diabetes mellitus alone. The median cfPWVs in diabetic nephropathy and vascular renal disease were comparable and significantly higher than median cfPWVs in other etiologies of ESRD. . The study suggests that the etiology of ESRD is independently associated with arterial stiffness among hemodialysis patients. Furthermore, arterial stiffness was higher among patients who developed renal sequelae of either diabetes mellitus or hypertension as compared with those who have a history of either diabetes mellitus or hypertension alone.

Citing Articles

Significance of 1,25-Dihydroxyvitamin D on Overall Mortality in Peritoneal Dialysis Patients with COVID-19.

Baralic M, Robajac D, Penezic A, Brkovic V, Gligorijevic N, Bontic A Nutrients. 2023; 15(9).

PMID: 37432214 PMC: 10181384. DOI: 10.3390/nu15092050.


Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population.

Kourtidou C, Rafailidis V, Varouktsi G, Kanakis E, Liakopoulos V, Vyzantiadis T J Pers Med. 2022; 12(7).

PMID: 35887636 PMC: 9319005. DOI: 10.3390/jpm12071139.


The Role of Cardio-Ankle Vascular Index as a Predictor of Mortality in Patients on Maintenance Hemodialysis.

Murakami K, Inayama E, Itoh Y, Tuchiya S, Iwasaki M, Tamura N Vasc Health Risk Manag. 2021; 17:791-798.

PMID: 34880622 PMC: 8648086. DOI: 10.2147/VHRM.S339769.


Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study.

Duong T, Shih C, Wong T, Chen H, Chen T, Hsu Y Biomed Res Int. 2019; 2019:1541593.

PMID: 31309101 PMC: 6594339. DOI: 10.1155/2019/1541593.


Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.

Sakura T, Morioka T, Shioi A, Kakutani Y, Miki Y, Yamazaki Y Cardiovasc Diabetol. 2017; 16(1):62.

PMID: 28486964 PMC: 5424398. DOI: 10.1186/s12933-017-0545-3.

References
1.
. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

2.
Nichols W, Denardo S, Wilkinson I, Mceniery C, Cockcroft J, ORourke M . Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich). 2008; 10(4):295-303. PMC: 8110097. DOI: 10.1111/j.1751-7176.2008.04746.x. View

3.
Guerin A, Blacher J, Pannier B, Marchais S, Safar M, London G . Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001; 103(7):987-92. DOI: 10.1161/01.cir.103.7.987. View

4.
Safar M, Blacher J, Pannier B, Guerin A, Marchais S, Guyonvarch P . Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002; 39(3):735-8. DOI: 10.1161/hy0202.098325. View

5.
Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G . Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99(18):2434-9. DOI: 10.1161/01.cir.99.18.2434. View